AstraZeneca and Oracle Partner on AI for Clinical Trials
Oct 20, 2026
Healthcare
Renalytix and Carna Health Partner on AI Kidney Disease Management
May 12, 2026
Renalytix and Carna Health have announced a partnership integrating the kidneyintelX.dkd diagnostic test with Carna Health’s AI platform to improve early detection and management of chronic kidney disease.
Renalytix and Carna Health have announced a partnership to improve how health systems identify and manage chronic kidney disease, according to a press release.
The collaboration integrates Renalytix’s FDA approved kidneyintelX.dkd test, which predicts the risk of kidney function decline in patients with type 2 diabetes and early stage chronic kidney disease, with Carna Health’s AI driven digital prevention and care management platform.
The combined approach is designed to help health systems move from traditional detection to risk guided, personalized care pathways. This integration aims to support earlier interventions for patients at risk of kidney failure and reduce the frequency of emergency dialysis starts.
The companies stated that the partnership could help address the high costs associated with chronic kidney disease, which currently exceeds 130 billion dollars in annual Medicare spending.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Nov 13 ETR survey: Claude leads enterprise AI tools on satisfaction and spending plans Nov 13 Peter Sarlin's PostScriptum takes majority stake in Finnish AI deployment firm Brillian Nov 13 Gondola says Codex lifted engineering output 25% as revenue more than doubled Nov 13 DuPont teams with Microsoft and NobleAI to speed up R&D with AI Nov 13 Korean AI startups fear Huang exit could delay planned NVIDIA investmentsMore from Life Sciences
Nov 13 Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 13 Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types Nov 13 Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners Nov 13 Sheinbaum meets OpenAI president Greg Brockman on AI in Mexican healthcareFree newsletter
Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
iReprogram and University of Michigan Launch AI Diabetes Cell Initiative
Oct 21, 2026
Biotech
ACL Digital Launches AgentixCare for Healthcare Operations
Oct 22, 2026
Healthcare
Revive Health and FitOn Health Combine Into AI Healthcare Platform
Nov 02, 2026
Acquisitions
Boehringer Ingelheim and Microsoft to Study Digital Patient Twins
Oct 23, 2026
Life Sciences
Chris Hemsworth co-founds KINSYN, a wellness platform that uses AI on medical and wearable data
Nov 12, 2026
Healthcare
Free, six days a week
Daily AI Brief: the AI news that matters, in your inbox.